Chemopotentiation by PARP inhibitors in cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference56 articles.
1. The PARP superfamily;Ame;Bioessays,2004
2. NAD(+)-dependent repair of damaged DNA by human cell extracts;Satoh;J Biol Chem,1993
3. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1;Schreiber;J Biol Chem,2002
4. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion;Ha;Proc Natl Acad Sci USA,1999
5. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor;Yu;Science,2002
Cited by 165 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PARP Inhibitors for Breast Cancer Treatment;JAMA Oncology;2024-05-01
2. Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?;Exploration of Targeted Anti-tumor Therapy;2023-12-27
3. Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye;Future Oncology;2023-11-28
4. Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07
5. Novel treatment strategies for Triple-negative breast cancers: A comprehensive review;Hacettepe University Journal of the Faculty of Pharmacy;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3